Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.

Hlatky MA, Douglas PS, Cook NL, Wells B, Benjamin EJ, Dickersin K, Goff DC, Hirsch AT, Hylek EM, Peterson ED, Roger VL, Selby JV, Udelson JE, Lauer MS.

J Am Coll Cardiol. 2012 Aug 14;60(7):569-80. doi: 10.1016/j.jacc.2011.12.057. Epub 2012 Jul 11.

2.

Comparative effectiveness research in lung diseases and sleep disorders: recommendations from the National Heart, Lung, and Blood Institute workshop.

Lieu TA, Au D, Krishnan JA, Moss M, Selker H, Harabin A, Taggart V, Connors A; Comparative Effectiveness Research in Lung Diseases Workshop Panel..

Am J Respir Crit Care Med. 2011 Oct 1;184(7):848-56. doi: 10.1164/rccm.201104-0634WS.

3.

The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop.

Blajchman MA, Carson JL, Eikelboom JW, Heddle NM, Lacroix J, Lauer MS, Platt R, Tilley B, Triulzi D, Vickers AJ, Yusuf S, Glynn S, Mondoro TH, Wagner E.

Transfusion. 2012 Jun;52(6):1363-78. doi: 10.1111/j.1537-2995.2012.03640.x. Epub 2012 Apr 9.

PMID:
22486525
4.

Comparative effectiveness research in cancer genomics and precision medicine: current landscape and future prospects.

Simonds NI, Khoury MJ, Schully SD, Armstrong K, Cohn WF, Fenstermacher DA, Ginsburg GS, Goddard KA, Knaus WA, Lyman GH, Ramsey SD, Xu J, Freedman AN.

J Natl Cancer Inst. 2013 Jul 3;105(13):929-36. doi: 10.1093/jnci/djt108. Epub 2013 May 9.

5.

Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.

Douglas PS, Taylor A, Bild D, Bonow R, Greenland P, Lauer M, Peacock F, Udelson J.

Circ Cardiovasc Imaging. 2009 Jul;2(4):339-48. doi: 10.1161/CIRCIMAGING.108.123999.

7.

Can CER be an effective tool for change in the development and assessment of new drugs and technologies?

Brixner DI, Watkins JB.

J Manag Care Pharm. 2012 Jun;18(5 Supp A):S06-11.

PMID:
22663293
8.

Comparative effectiveness research: a progress report.

Sox HC.

Ann Intern Med. 2010 Oct 5;153(7):469-72. doi: 10.7326/0003-4819-153-7-201010050-00269. Epub 2010 Aug 2.

PMID:
20679544
9.

Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.

Douglas PS, Taylor A, Bild D, Bonow R, Greenland P, Lauer M, Peacock F, Udelson J.

JACC Cardiovasc Imaging. 2009 Jul;2(7):897-907. doi: 10.1016/j.jcmg.2009.01.018.

10.

Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.

Douglas PS, Taylor A, Bild D, Bonow R, Greenland P, Lauer M, Peacock F, Udelson J.

J Cardiovasc Comput Tomogr. 2009 Jul-Aug;3(4):212-23. doi: 10.1016/j.jcct.2009.06.001. Epub 2009 Jun 6.

PMID:
19577208
11.

Comparative effectiveness research - what is it and how does one do it?

Goss CH, Tefft N.

Paediatr Respir Rev. 2013 Sep;14(3):152-6. doi: 10.1016/j.prrv.2013.06.006. Epub 2013 Jul 23.

PMID:
23890806
12.

Comparative effectiveness research in practice and policy for radiation oncology.

Lawrence WF.

Semin Radiat Oncol. 2014 Jan;24(1):54-60. doi: 10.1016/j.semradonc.2013.09.001. Review.

PMID:
24314343
14.

Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute.

Gibbons GH, Shurin SB, Mensah GA, Lauer MS.

J Am Coll Cardiol. 2013 Oct 8;62(15):1396-8. doi: 10.1016/j.jacc.2013.08.003. No abstract available.

15.

Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.

Douglas PS, Taylor A, Bild D, Bonow R, Greenland P, Lauer M, Peacock F, Udelson J.

J Am Soc Echocardiogr. 2009 Jul;22(7):766-73. doi: 10.1016/j.echo.2009.05.026. Review. Erratum in: J Am Soc Echocardiogr. 2009 Aug;22(8):882.

16.

Comparative effectiveness research (CER): a summary of AHRQ's CER on therapies for rheumatoid arthritis.

Oderda GM, Balfe LM.

J Manag Care Pharm. 2011 Nov-Dec;17(9 Suppl B):S19-24.

17.

It is important to distinguish CER from patient-centered outcomes research. Introduction.

Brixner DI, Oderda G.

J Manag Care Pharm. 2012 May;18(4 Suppl A):S3-4. No abstract available.

18.

International participation in cardiovascular randomized controlled trials sponsored by the National Heart, Lung, and Blood Institute.

Kim ES, Carrigan TP, Menon V.

J Am Coll Cardiol. 2011 Aug 9;58(7):671-6. doi: 10.1016/j.jacc.2011.01.066.

19.

The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.

McGhan WF, Al M, Doshi JA, Kamae I, Marx SE, Rindress D.

Value Health. 2009 Nov-Dec;12(8):1086-99. doi: 10.1111/j.1524-4733.2009.00605.x. Epub 2009 Sep 10.

20.

Cardiovascular tissue engineering research support at the National Heart, Lung, and Blood Institute.

Lundberg MS.

Circ Res. 2013 Apr 12;112(8):1097-103. doi: 10.1161/CIRCRESAHA.112.300638. Review.

Supplemental Content

Support Center